Astromech
AI-driven biological intelligence platform
About
Astromech, spun out from Colossal Biosciences by founders Ben Lamm and George Church, is an AI biological data startup focusing on predictive modeling in biology. The company builds advanced AI models to forecast evolution, disease risks, and systemic biological vulnerabilities, accelerating deep R&D in biology. It combines AI with biological data to enable better predictive insights into complex biological systems, aiming to revolutionize biological science and healthcare. Astromech has quickly scaled funding, totaling $40.5M as of its seed extension round at a $2B valuation, positioning itself as a leading AI-driven bio intelligence company.
Products
-
Predictive Biological Models
— AI models forecasting evolution, disease risk, and systemic biological vulnerabilities to accelerate biological research and discovery.
Customer sectors: biotech, pharmaceutical, healthcare research
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Astromech — available to members.
